Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2010 1
2012 1
2014 1
2015 1
2017 3
2018 2
2019 4
2020 6
2021 5
2022 3
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.
Simmons K, Thomas JV, Ludford K, Willis JA, Higbie VS, Raghav KPS, Johnson B, Dasari A, Kee BK, Parseghian CM, Lee MS, Le PH, Morelli MP, Shen JP, Bent A, Vilar E, Wolff RA, Kopetz S, Overman MJ, Morris VK. Simmons K, et al. Among authors: morelli mp. Cancer Res Commun. 2023 Dec 11;3(12):2510-2517. doi: 10.1158/2767-9764.CRC-23-0340. Cancer Res Commun. 2023. PMID: 38085001 Free PMC article.
Next-Generation Approaches to Immuno-Oncology in GI Cancers.
Hecht JR, Mitchell J, Morelli MP, Anandappa G, Yang JC. Hecht JR, et al. Am Soc Clin Oncol Educ Book. 2023 Jun;43:e389072. doi: 10.1200/EDBK_389072. Am Soc Clin Oncol Educ Book. 2023. PMID: 37290032 Free article. Review.
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Cole CB, Morelli MP, Fantini M, Miettinen M, Fetsch P, Peer C, Figg WD, Yin T, Houston N, McCoy A, Lipkowitz S, Zimmer A, Lee JM, Pavelova M, Villanueva EN, Trewhitt K, Solarz BB, Fergusson M, Mavroukakis SA, Zaki A, Tsang KY, Arlen PM, Annunziata CM. Cole CB, et al. J Exp Clin Cancer Res. 2023 Apr 26;42(1):102. doi: 10.1186/s13046-023-02668-3. J Exp Clin Cancer Res. 2023. PMID: 37101182 Free PMC article. No abstract available.
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Cole CB, Morelli MP, Fantini M, Miettinen M, Fetsch P, Peer C, Figg WD, Yin T, Houston N, McCoy A, Lipkowitz S, Zimmer A, Lee JM, Pavelova M, Villanueva EN, Trewhitt K, Solarz BB, Fergusson M, Mavroukakis SA, Zaki A, Tsang KY, Arlen PM, Annunziata CM. Cole CB, et al. J Exp Clin Cancer Res. 2023 Mar 29;42(1):76. doi: 10.1186/s13046-023-02649-6. J Exp Clin Cancer Res. 2023. PMID: 36991390 Free PMC article. Clinical Trial.
Survival improvement for patients with metastatic colorectal cancer over twenty years.
Zeineddine FA, Zeineddine MA, Yousef A, Gu Y, Chowdhury S, Dasari A, Huey RW, Johnson B, Kee B, Lee MS, Morelli MP, Morris VK, Overman MJ, Parseghian C, Raghav K, Willis J, Wolff RA, Kawaguchi Y, Vauthey JN, Sun R, Kopetz S, Shen JP. Zeineddine FA, et al. NPJ Precis Oncol. 2023 Feb 13;7(1):16. doi: 10.1038/s41698-023-00353-4. NPJ Precis Oncol. 2023. PMID: 36781990 Free PMC article.
Circulating Monocyte-Like Myeloid Derived Suppressor Cells and CD16 Positive Monocytes Correlate With Immunological Responsiveness of Tuberculosis Patients.
Amiano NO, Pellegrini JM, Morelli MP, Martinena C, Rolandelli A, Castello FA, Casco N, Ciallella LM, de Casado GC, Armitano R, Stupka J, Gallego C, Palmero DJ, García VE, Tateosian NL. Amiano NO, et al. Among authors: morelli mp. Front Cell Infect Microbiol. 2022 Mar 14;12:841741. doi: 10.3389/fcimb.2022.841741. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35360105 Free PMC article.
34 results